ArticleHealth science reports2026
Genetic Susceptibility to Rheumatic Heart Disease: A Narrative Literature Review Highlighting Evidence From African Populations and Research Gaps in Sudan.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Rheumatic heart disease (RHD) remains a significant public health burden in low- and middle-income countries, particularly in sub-Saharan Africa. Although socioeconomic factors contribute to disease persistence, genetic susceptibility plays a critical role in determining progression from Group A Streptococcal infection to acute rheumatic fever (ARF) and chronic RHD. Understanding these genetic influences is essential for improving early detection and prevention strategies. Methods: A comprehensive narrative literature search was conducted using PubMed, Scopus, and Google Scholar to identify studies examining genetic susceptibility to RHD. Eligible articles included those focused on immune response genes, regional epidemiology, and genetic markers such as HLA alleles, cytokine polymorphisms, and genome-wide association study (GWAS) findings. Results: HLA class II genes-particularly HLA-DR and HLA-DQ-have shown consistent associations with RHD across African, South Asian, and Latin American populations. Cytokine gene polymorphisms, including TNF-α (-308A), IL-6 (-174G > C), and IL-10 (-1082G > A), have been linked to variations in inflammatory response and disease severity. GWAS have identified several novel loci, including the chromosome 11q21 region, which is unique to African cohorts, highlighting population-specific genetic risk. Despite Sudan's high RHD burden, no dedicated genetic studies have been conducted among Sudanese patients, leaving a substantial knowledge gap regarding local susceptibility patterns. Conclusion: Current evidence underscores the importance of genetic factors in RHD pathogenesis, yet Sudan remains significantly underrepresented in genetic research. Conducting Sudan-specific studies could identify population-specific alleles, strengthen early screening strategies, and guide tailored prevention efforts. Such work would also contribute valuable data to the broader understanding of RHD genetics across Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.